临床药师对1例美罗培南致婴儿极度血小板增多症的药学干预Clinical Pharmacist 's Pharmaceutical Intervention to A Case of Severe Thrombocytosis Caused by Meropenem in An Infant
吴海燕,高翔,洪晓丹,陈杰
Wu Haiyan,GAO Xiang,HONG Xiaodan,CHEN Jie
摘要(Abstract):
目前引起血小板增多的药物非常少见,但严重血小板增多可引起血栓栓塞风险,可危及患者生命,应引起重视。临床药师针对出生6个月男性患儿在用药过程中出现极度血小板增多症(达1 038×109/L),在病情危急情况下利用自己专业知识,排除疾病等因素,从复杂的用药中判断出美罗培南所致不良反应,并进行了药学干预,避免了不良后果,体现了临床药师的价值。
Few drugs could cause thrombocytosis. However,sever thrombocytosis can cause thrombosis and even cause death,thus special attention should be paid to thrombocytosis. In the case of a 6-month old boy developing a severe thrombocytosis during meropenem treatment course,clinical pharmacists used their professional knowledge to rull out the effect of disease state and identify the adverse effect caused by meropenem out of complexity. Pharmaceutical intervention was given and adverse outcome was prevented.
关键词(KeyWords):
美罗培南;血小板增多;不良反应;临床药师
meropenem;thrombocytosis;adverse drug reaction;clinical pharmacist
基金项目(Foundation):
作者(Author):
吴海燕,高翔,洪晓丹,陈杰
Wu Haiyan,GAO Xiang,HONG Xiaodan,CHEN Jie
参考文献(References):
- [1]昊吉芹,俞逊婕,许小平,等.感染相关性极度血小板增多症一例[J].中华内科杂志,2007,46(12):1039-1040.
- [2]胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:1804-1806.
- [3]陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2012:567.
- [4]夏先波,戴缦,杨峰.美洛培南致高龄患者血小板计数降低1例[J].人民军医.2012.55(10):951.
- [5]张俊忠.美罗培南诱发严重血小板减少症1例[J].药物流行病学杂志,2004,13(6):350.
- [6]林华,李金龙,王磊.美罗培南致血小板降低1例[J].中国药业,2008,17(5):25.
- [7]Johansen ME,Jensen JU,Bestle MH,et al.The potential of antimicrobials to induce thrombocytopenia in critically ill patients:data from a randomized controlled trial.PLo S One,2013,8(11):e81477.
- [8]国家食品药品监督管理局药品安全监管司,国家药品不良反应中心编[S].药品不良反应报告和监测工作手册,2005:46.